M.D. Anderson Cancer Center — Clinical Trial Pipeline

M.D. Anderson Cancer Center has 53 registered trials in the index.

Trials (53)

PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide Phase 2 · M.D. Anderson Cancer Center
The Exceptional Patient in Cancer Care N/A · M.D. Anderson Cancer Center
Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver Phase 2 · M.D. Anderson Cancer Center
Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC) Phase 1/2 · M.D. Anderson Cancer Center
Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) Phase 2 · M.D. Anderson Cancer Center
18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer Phase 1 · M.D. Anderson Cancer Center
Nuclear and Near-Infrared (NIR) Imaging in Melanoma Phase 1 · M.D. Anderson Cancer Center
Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome Phase 2 · M.D. Anderson Cancer Center
Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome Phase 1/2 · M.D. Anderson Cancer Center
Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis Early Phase 1 · M.D. Anderson Cancer Center
rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin Chemotherapy N/A · M.D. Anderson Cancer Center
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study) Phase 2 · M.D. Anderson Cancer Center
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies N/A · M.D. Anderson Cancer Center
Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer Phase 1 · M.D. Anderson Cancer Center
Mind-Body Intervention in Glioma Couples N/A · M.D. Anderson Cancer Center
Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia Phase 1/2 · M.D. Anderson Cancer Center
Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer Phase 2 · M.D. Anderson Cancer Center
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. Phase 3 · M.D. Anderson Cancer Center
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas Phase 1 · M.D. Anderson Cancer Center
Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood Phase 1 · M.D. Anderson Cancer Center
Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA) Phase 2 · M.D. Anderson Cancer Center
Non Invasive Oral Cancer Screening Among HIV Infected Individuals Early Phase 1 · M.D. Anderson Cancer Center
Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma Phase 2 · M.D. Anderson Cancer Center
EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy N/A · M.D. Anderson Cancer Center
Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML Phase 1/2 · M.D. Anderson Cancer Center
Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment Phase 2 · M.D. Anderson Cancer Center
Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis Phase 2 · M.D. Anderson Cancer Center
Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work N/A · M.D. Anderson Cancer Center
Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases Phase 2 · M.D. Anderson Cancer Center
Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery Phase 2 · M.D. Anderson Cancer Center
Young-Onset Colorectal Cancer N/A · M.D. Anderson Cancer Center
Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer Phase 2 · M.D. Anderson Cancer Center
Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) Phase 2 · M.D. Anderson Cancer Center
Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients Phase 2 · M.D. Anderson Cancer Center
Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas Early Phase 1 · M.D. Anderson Cancer Center
Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure N/A · M.D. Anderson Cancer Center
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer Phase 2 · M.D. Anderson Cancer Center
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers Phase 2/3 · M.D. Anderson Cancer Center
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies N/A · M.D. Anderson Cancer Center
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer Phase 1/2 · M.D. Anderson Cancer Center
Three-Dimensional Fluoroscopic Guidance During Transbronchial Cryobiopsy N/A · M.D. Anderson Cancer Center
An Open-Label, Single Center Phase 2 Study of Magrolimab, Rituximab and Radiation as Bridging Strategy Before CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-cell Lymphoma Phase 2 · M.D. Anderson Cancer Center
A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia Phase 1 · M.D. Anderson Cancer Center
Survivorship in Lynch Syndrome Families N/A · M.D. Anderson Cancer Center
Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases Phase 2 · M.D. Anderson Cancer Center
Developing a Culturally Relevant Supportive Care Program for Black Patients Dealing With Advanced Cancer N/A · M.D. Anderson Cancer Center
Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease N/A · M.D. Anderson Cancer Center
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases Phase 1 · M.D. Anderson Cancer Center
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast N/A · M.D. Anderson Cancer Center
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) Phase 3 · M.D. Anderson Cancer Center

Related landscapes

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.